ExoZymes Inc. Reports Executive and Director Changes

Ticker: EXOZ · Form: 8-K · Filed: Jun 20, 2025 · CIK: 2010788

Exozymes Inc. 8-K Filing Summary
FieldDetail
CompanyExozymes Inc. (EXOZ)
Form Type8-K
Filed DateJun 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation

TL;DR

ExoZymes board shakeup and new exec comp details filed.

AI Summary

ExoZymes Inc. announced on June 17, 2025, changes in its executive team and board of directors. The company also disclosed compensatory arrangements for certain officers. These changes are effective as of the report date.

Why It Matters

Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in executive and director roles, along with compensatory arrangements, can introduce uncertainty regarding future company direction and financial stability.

Key Players & Entities

  • EXOZYMES INC. (company) — Registrant
  • Invizyne Technologies Inc (company) — Former Company Name
  • June 17, 2025 (date) — Date of earliest event reported

FAQ

What specific roles have changed within ExoZymes Inc.'s executive team or board?

The filing indicates changes in 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not specify the exact roles or individuals involved in this summary.

What are the details of the compensatory arrangements for certain officers?

The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specific details of these arrangements are not provided in this summary.

When was the name change from Invizyne Technologies Inc. to ExoZymes Inc. effective?

The name change from Invizyne Technologies Inc. to ExoZymes Inc. was effective on February 5, 2024.

What is the principal executive office address for ExoZymes Inc.?

The principal executive offices are located at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016.

What is the SIC code for ExoZymes Inc.?

The Standard Industrial Classification (SIC) code for ExoZymes Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding EXOZYMES INC. (EXOZ).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.